Back to Search Start Over

Clinical accuracy of OncoPredict HPV Quantitative Typing (QT) assay on self-samples.

Authors :
Latsuzbaia, Ardashel
Martinelli, Marianna
Giubbi, Chiara
Cuschieri, Kate
Elasifer, Hana
Iacobone, Anna D.
Bottari, Fabio
Piana, Andrea F.
Pietri, Roberto
Tisi, Giancarlo
Odicino, Franco
Cocuzza, Clementina E.
Arbyn, Marc
Source :
Journal of Clinical Virology. Dec2024, Vol. 175, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

• Accuracy of full genotyping oncopredict QT assay was evaluated on self-samples. • HPV testing in self-samples was similarly sensitive for CIN2+ versus cervical samples. • OncoPredict QT assay provides genotype specific viral load normalised by cellularity. The VALHUDES initiative was established to assess the clinical accuracy of HPV assays to detect cervical precancers using urine and vaginal self-samples compared to cervical clinician-collected samples. Here, the clinical performance of OncoPredict HPV Quantitative Typing (QT) assay (OncoPredict QT) was evaluated. 490 women referred to colposcopy self-collected a urine and a vaginal specimen using Colli-Pee and FLOQSwab, respectively. Subsequently, a colposcopy was performed, and a cervical sample was collected with Cervex-Brush, followed by biopsy if clinically indicated. Vaginal samples were transported dry and resuspended in 5 mL of eNAT medium, whilst cervical brushings were immediately transferred in 20 mL ThinPrep. The clinical sensitivity of OncoPredict HPV QT testing for CIN2+ in urine and vaginal self-samples was similar to cervical samples (ratios of 0.99 [95 % CI 0.94–1.05] and 1.00 [95 % CI 0.96–1.04]), respectively, when manufacturer's cut-offs were applied. The specificity for <CIN2 on both self-samples was lower than on cervical samples (urine/cervical ratio = 0.91 [95 % CI 0.84–0.98]; vaginal/cervical ratio = 0.90 [95 % CI 0.84–0.98]). Cut-off optimisation improved specificity without compromising sensitivity. Median viral load values adjusted for cellularity were significantly higher in cervical samples compared to urine or vaginal self-samples, in general for all 12 high-risk HPV and in particular for HPV16, 18, 31, 33, 35, 45, 51, 58 (p < 0.05). No difference was observed in median viral loads between urine and vaginal samples. Following cut-off optimisation OncoPredict HPV QT assay demonstrated similar accuracy on self-collected versus cervical samples. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13866532
Volume :
175
Database :
Academic Search Index
Journal :
Journal of Clinical Virology
Publication Type :
Academic Journal
Accession number :
181193696
Full Text :
https://doi.org/10.1016/j.jcv.2024.105737